Natera is trading 7.95% up at $337.59 after continued investor response to August 6 earnings showing $752.8 million in revenue, record test volumes, and raised 2026 revenue guidance to $2.85 billion–$2.91 billion.
- Results substantially exceeded expectations: 38% year-over-year revenue growth and more than 1.04 million tests processed.
- The move follows a 21.37% August 7 gain and pullback, suggesting earnings momentum, not a newly reported August 12 catalyst.
- Broader markets are modestly higher before CPI, providing additional support.